Patients on Eli Lilly's Mounjaro were more likely to lose weight and experienced larger reductions in body weight compared to those on Novo Nordisk's Ozempic.
from Health and Science https://ift.tt/R5Lpvb0
https://ift.tt/5L2UPMC
https://ift.tt/4f6FyKX
No comments:
Post a Comment